Biomarkers in the Retina for Prognosticating Mental Health Treatments
NCT06363968
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Title: ERG as a potential biomarker of SSRI-responsive PTSD: A pilot study Posttraumatic stress disorder (PTSD) affects many individuals who experience a traumatic event. Previous studies suggest that there is a connection between the brain and the retina, and that the electroretinogram (ERG) may be a valuable biomarker to tell us more about signals in the brain that are related to mental health disorders like PTSD.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- PTSD
- Posttraumatic Stress Disorder
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 21 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- VA Puget Sound Health Care System
- Last updated on ClinicalTrials.gov
- April 12, 2024
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Washington · 1
- VA Puget Sound Health Care System · Seattle, WA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.